Your shopping cart is currently empty

Tylosin (Tylosine) is a macrolide antibiotic obtained from cultures of Streptomyces fradiae. The drug is effective against many microorganisms in animals but not in humans.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $46 | - | In Stock | |
| 50 mg | $59 | - | In Stock | |
| 100 mg | $72 | - | In Stock | |
| 500 mg | $176 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $30 | - | In Stock |
| Description | Tylosin (Tylosine) is a macrolide antibiotic obtained from cultures of Streptomyces fradiae. The drug is effective against many microorganisms in animals but not in humans. |
| In vivo | Tylosin and its phosphate and tartrate salts are used in pigs, cattle and poultry for the treatment of infections caused by organisms sensitive to tylosin. They mav be administered to calves oralv in the milk renlacer at a dose ot 40 moiko body weight (bw) and to cattle, by intramuscular injection, at a dose of 4-10 mg/kg bw. It may be administered in the drinking-water af a dose of 25 mg/kg bw, in the feed at a dose of 3-7 mg/kg bw or by intramuscularl injection at a dose of 2-10 mg/kg bw. Tylosin is administered to poultry in thel drinking-water at a dose equivalent to 75 mg/kg bw. It is used primarily in thel treatment of chronic respiratory diseasecomplex in chickens and infectioussinusitis in turkeys caused by Mycoplasma gallisepticum. |
| Synonyms | Tylosine, Tylosin A, Tylocine, Fradizine |
| Molecular Weight | 916.10 |
| Formula | C46H77NO17 |
| Cas No. | 1401-69-0 |
| Smiles | [H][C@@]1(C[C@@](C)(O)[C@@H](O)[C@H](C)O1)O[C@@H]1[C@@H](C)O[C@@]([H])(O[C@H]2[C@@H](CC=O)C[C@@H](C)C(=O)\C=C\C(\C)=C\[C@H](CO[C@@H]3O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]3OC)[C@@H](CC)OC(=O)C[C@@H](O)[C@@H]2C)[C@H](O)[C@H]1N(C)C |
| Relative Density. | 1.1424 g/cm3 (Estimated) |
| Storage | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 91 mg/mL (99.33 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (3.6 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.